Zentalis Pharmaceuticals
ZNTL
$11.06
Share price
0.68%
Change (1 day)
-49.80%
Change (1 year)
Categories
Zentalis Pharmaceuticals (ZNTL) - Cash on Hand
Cash on Hand as of December 2023 : $0.48 B
According to Zentalis Pharmaceuticals's latest financial reports the company has $0.48 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Zentalis Pharmaceuticals - Cash on Hand chart (from 2019 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.48 B | 10.41% |
| 2022-12-31 | $0.43 B | 28.68% |
| 2021-12-31 | $0.33 B | 0.41% |
| 2020-12-31 | $0.33 B | 403.38% |
| 2019-12-31 | $67.24 M | 167.34% |
| 2018-12-31 | $25.15 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | $95.88 M | -80.15% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | $20.82 M | -95.69% | 🇺🇸 USA |